EPISODE · Apr 23, 2025 · 22 MIN
Anti-obesity drugs for the gastroenterologists
from FG Podcast · host BMJ Group
This podcast focusses on the Frontline Gastroenterology review paper on anti-obesity medications, authored by Dr Lisa Sharkey. From GLP1-RA GI side effects to nutritional risks, MASLD management and endoscopy considerations — this is a must-listen for every practicing and trainee gastroenterologist navigating the metabolic medicine revolution. Read the manuscript on this link: Anti-obesity drugs for the gastroenterologists We hope you enjoy the #FGPodcast. Please follow @FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
What this episode covers
This podcast focusses on the Frontline Gastroenterology review paper on anti-obesity medications, authored by Dr Lisa Sharkey. From GLP1-RA GI side effects to nutritional risks, MASLD management and endoscopy considerations — this is a must-listen for every practicing and trainee gastroenterologist navigating the metabolic medicine revolution. Read the manuscript on this link: Anti-obesity drugs for the gastroenterologists We hope you enjoy the #FGPodcast. Please follow @FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
NOW PLAYING
Anti-obesity drugs for the gastroenterologists
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m